Sansho Pharmaceutical

Sansei Seiyaku, often referred to in English contexts as Sansho Pharmaceutical, is a Japanese pharmaceutical and cosmetics company specializing in the development of active ingredients for skin care and quasi-drugs. The company is most notably recognized for being the first to develop and commercialize Kojic Acid as a skin-whitening agent, a breakthrough that established its reputation in the dermo-cosmetic industry. Beyond whitening agents, Sansei Seiyaku focuses on anti-aging, hair growth, and anti-inflammatory compounds derived from natural sources. The company operates as both a developer of proprietary ingredients and a contract manufacturer (CMO) for high-end cosmetic brands. Its business model integrates research, development, and manufacturing to provide functional ingredients backed by dermatological science.